Fresh2 Group Limited

OTCPK:FREH.Y Stock Report

Market Cap: US$222.3k

Fresh2 Group Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Fresh2 Group's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

AnPac Bio announces plan to implement ADS ratio change

Oct 18

AnPac Bio-Medical Science announces management changes

Oct 03

AnPac Bio-Medical Science signed equity investment totaling $3.67M with new investor Group

Sep 27

AnPac Bio appoints Yuyang Cui as co-chief executive officer

Aug 05

AnPac Bio stock soars 15% after securing first disease treatment patent in U.S.

Jun 18

AnPac Bio wins new US patent for multi-cancer detection

Feb 01

AnPac Bio (ANPC) skyrockets 136% on advancement in detecting pre-cancer diseases

Dec 14

Industry Analysts Just Upgraded Their AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Revenue Forecasts By 55%

Dec 11
Industry Analysts Just Upgraded Their AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Revenue Forecasts By 55%

AnPac Bio-Medical rallies on Q3 record test volume; FY20 revenue estimated at +100%

Nov 25

AnPac Bio's Chinese company secures COVID-19 nucleic acid test certification; shares +33%

Nov 02

Revenue & Expenses Breakdown

How Fresh2 Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:FREH.Y Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2317-13611612
31 Mar 2311-110929
31 Dec 2212-1028310
30 Sep 2211-61588
30 Jun 229-705811
31 Mar 2218-1049215
31 Dec 2118-11910216
30 Sep 2125-989912
30 Jun 2126-819210
31 Mar 2122-889412
31 Dec 2021-809412
30 Sep 2012-11210314
30 Jun 2011-12210713
31 Mar 2010-1059111
31 Dec 1911-1018310
30 Sep 1912-69649
31 Dec 1810-423810
31 Dec 176-393111

Quality Earnings: Insufficient data to determine if FREH.Y has high quality earnings.

Growing Profit Margin: Insufficient data to determine if FREH.Y's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if FREH.Y's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare FREH.Y's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if FREH.Y's earnings growth over the past year exceeded the Biotechs industry average.


Return on Equity

High ROE: FREH.Y has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 01:45
End of Day Share Price 2025/03/14 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Fresh2 Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Theodore O'NeillLitchfield Hills Research, LLC